3.23
price up icon1.25%   0.04
after-market Handel nachbörslich: 3.30 0.07 +2.17%
loading

Anixa Biosciences Inc Aktie (ANIX) Neueste Nachrichten

pulisher
Jun 15, 2025

Millennium Management LLC Acquires Shares of 11,028 Anixa Biosciences, Inc. (NASDAQ:ANIX) - Defense World

Jun 15, 2025
pulisher
Jun 14, 2025

Anixa Biosciences Announces Poster Presentation on Ovarian Cancer CAR-T Clinical Trial at the ESMO Gynaecological Cancers Congress 2025 - Kilgore News Herald

Jun 14, 2025
pulisher
Jun 12, 2025

Everything You Need to Know About the New Breast Cancer Vaccine - Vogue

Jun 12, 2025
pulisher
Jun 12, 2025

Bank of America Corp DE Sells 6,891 Shares of Anixa Biosciences, Inc. (NASDAQ:ANIX) - Defense World

Jun 12, 2025
pulisher
Jun 11, 2025

3 Promising Penny Stocks With Market Caps Over $100M - simplywall.st

Jun 11, 2025
pulisher
Jun 11, 2025

Anixa Biosciences’ (ANIX) Buy Rating Reaffirmed at D. Boral Capital - Defense World

Jun 11, 2025
pulisher
Jun 10, 2025

What Makes ANIXA BIOSCIENCES INC (ANIX) a Strong Momentum Stock: Buy Now? - Yahoo Finance

Jun 10, 2025
pulisher
Jun 10, 2025

Anixa Biosciences' Breast Cancer Vaccine Receives National News Coverage - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

Anixa Biosciences' Breast Cancer Vaccine Receives National News Coverage | ANIX Stock News - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

Anixa Biosciences (ANIX) Maintains 'Buy' Rating with $10 Price T - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

Anixa Biosciences (ANIX) Maintains 'Buy' Rating with $10 Price Target | ANIX Stock News - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

Revolutionary Breast Cancer Prevention Vaccine Gets Major Media Spotlight: How It Could Eradicate Cancer - Stock Titan

Jun 10, 2025
pulisher
Jun 09, 2025

Anixa Biosciences (ANIX) to Present at ESMO Gynaecological Cance - GuruFocus

Jun 09, 2025
pulisher
Jun 09, 2025

Anixa Biosciences Announces Poster Presentation on Ovarian Cance - GuruFocus

Jun 09, 2025
pulisher
Jun 09, 2025

Anixa Biosciences Announces Poster Presentation On Ovarian Cancer CAR-T Clinical Trial At ESMO Gynaecological Cancers Congress 2025 - MarketScreener

Jun 09, 2025
pulisher
Jun 09, 2025

Breakthrough CAR-T Therapy for Ovarian Cancer: Anixa's Phase 1 Trial Results Coming at ESMO 2025 - Stock Titan

Jun 09, 2025
pulisher
Jun 09, 2025

Jane Street Group LLC Purchases New Shares in Anixa Biosciences, Inc. (NASDAQ:ANIX) - Defense World

Jun 09, 2025
pulisher
Jun 07, 2025

Anixa Biosciences (NASDAQ:ANIX) Upgraded by Wall Street Zen to Hold Rating - Defense World

Jun 07, 2025
pulisher
Jun 07, 2025

All You Need to Know About Anixa Biosciences (ANIX) Rating Upgrade to Buy - MSN

Jun 07, 2025
pulisher
Jun 06, 2025

Kalkine Lists top companies in the nasdaq Featuring Innovative Biotech Like Anixa Biosciences - Kalkine Media

Jun 06, 2025
pulisher
Jun 06, 2025

FY2025 EPS Forecast for Anixa Biosciences Boosted by Analyst - Defense World

Jun 06, 2025
pulisher
Jun 05, 2025

CEO Amit Kumar Increases Stake in Anixa Biosciences Inc with Rec - GuruFocus

Jun 05, 2025
pulisher
Jun 05, 2025

Anixa Biosciences CEO Amit Kumar acquires $28,500 in stock - Investing.com Australia

Jun 05, 2025
pulisher
Jun 05, 2025

Anixa Biosciences CEO Amit Kumar acquires $28,500 in stock By Investing.com - Investing.com Canada

Jun 05, 2025
pulisher
Jun 05, 2025

Are Medical Stocks Lagging Anixa Biosciences (ANIX) This Year? - Yahoo Finance

Jun 05, 2025
pulisher
Jun 04, 2025

H.C. Wainwright maintains Buy rating on Anixa Biosciences stock By Investing.com - Investing.com UK

Jun 04, 2025
pulisher
Jun 04, 2025

Northern Trust Corp Trims Stock Position in Anixa Biosciences, Inc. (NASDAQ:ANIX) - Defense World

Jun 04, 2025
pulisher
Jun 03, 2025

Anixa Biosciences' Breast Cancer Vaccine Featured in NewsNation Interview - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Anixa Biosciences' Breast Cancer Vaccine Featured in NewsNation Interview | ANIX Stock News - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Revolutionary Breast Cancer Prevention Vaccine Hits Major Milestone: Phase 1 Trial Fully Enrolled - Stock Titan

Jun 03, 2025
pulisher
Jun 02, 2025

Anixa Biosciences (ANIX) Concludes Enrollment for Breast Cancer Vaccine Trial | ANIX Stock News - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

Anixa Biosciences Announces Completion Of Enrollment In Phase 1 Trial Of Breast Cancer Vaccine - MarketScreener

Jun 02, 2025
pulisher
Jun 02, 2025

Anixa Biosciences Announces Completion of Enrollment in Phase 1 Trial of Breast Cancer Vaccine - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

Anixa Biosciences Announces Completion of Enrollment in Phase 1 Trial of Breast Cancer Vaccine | ANIX Stock News - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

Revolutionary Breast Cancer Vaccine Achieves Major Milestone: 70% of Patients Show Promising Immune Response - Stock Titan

Jun 02, 2025
pulisher
May 31, 2025

ANIXA BIOSCIENCES Earnings Preview: Recent $ANIX Insider Trading, Hedge Fund Activity, and More - Nasdaq

May 31, 2025
pulisher
May 31, 2025

Anixa Biosciences to Present at the iAccess Alpha Virtual Best Ideas Winter Conference 2024 on December 10 - marketscreener.com

May 31, 2025
pulisher
May 30, 2025

Anixa Biosciences’ (ANIX) “Buy” Rating Reaffirmed at D. Boral Capital - Defense World

May 30, 2025
pulisher
May 29, 2025

Anixa Biosciences (ANIX) Retains 'Buy' Rating with $10 Price Tar - GuruFocus

May 29, 2025
pulisher
May 29, 2025

Anixa Biosciences (ANIX) Retains 'Buy' Rating with $10 Price Target | ANIX Stock News - GuruFocus

May 29, 2025
pulisher
May 28, 2025

Anixa Biosciences Inc SEC 10-Q Report - TradingView

May 28, 2025
pulisher
May 27, 2025

Anixa Biosciences (ANIX) Expected to Announce Earnings on Tuesday - Defense World

May 27, 2025
pulisher
May 19, 2025

Anixa Biosciences CEO Provides Letter to Shareholders Outlining - GuruFocus

May 19, 2025
pulisher
May 19, 2025

Anixa Biosciences CEO Provides Letter to Shareholders Outlining Significant Progress and Advancement Towards Potentially Transformative Milestones - Nasdaq

May 19, 2025
pulisher
May 19, 2025

Breakthrough: Anixa's Cancer Vaccine Shows 70% Response Rate While CAR-T Therapy Extends Patient Survival - Stock Titan

May 19, 2025
pulisher
May 12, 2025

Anixa Biosciences Announces Poster Presentation on Ovarian Cancer CAR-T Clinical Trial at the American Society of Clinical Oncology (ASCO) Annual Meeting - Stock Titan

May 12, 2025
pulisher
May 09, 2025

Renaissance Technologies LLC Has $34,000 Stock Holdings in Anixa Biosciences, Inc. (NASDAQ:ANIX) - Defense World

May 09, 2025
pulisher
May 05, 2025

ANIXAnixa Biosciences Inc Latest Stock News & Market Updates - Stock Titan

May 05, 2025
pulisher
May 01, 2025

Anixa Biosciences, Inc. (NASDAQ:ANIX) Shares Acquired by LPL Financial LLC - Defense World

May 01, 2025
$20.30
price down icon 0.68%
$36.37
price up icon 0.50%
$24.55
price up icon 8.53%
$97.80
price down icon 0.45%
$110.00
price up icon 1.61%
biotechnology ONC
$245.49
price up icon 0.48%
Kapitalisierung:     |  Volumen (24h):